Boothbay Fund Management, LLC Natera, Inc. Put Options Transaction History

Boothbay Fund Management, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	BUY	$37.55 - $62.64 $116,404 - $194,184	3,100 Added 13.9%	25,400 $1.59 Million
Q3 2023 Nov 14, 2023	BUY	$43.4 - $62.52 $221,340 - $318,852	5,100 Added 29.65%	22,300 $986,000
Q2 2023 Aug 14, 2023	SELL	$47.08 - $55.16 $579,084 - $678,468	-12,300 Reduced 41.69%	17,200 $836,000
Q1 2023 May 15, 2023	BUY	$36.57 - $58.29 $157,251 - $250,647	4,300 Added 17.06%	29,500 $1.64 Million
Q4 2022 Feb 14, 2023	SELL	$34.17 - $47.91 $304,113 - $426,398	-8,900 Reduced 26.1%	25,200 $1.01 Million
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $18,465 - $28,340	500 Added 1.49%	34,100 $1.49 Million
Q2 2022 Aug 15, 2022	BUY	$28.13 - $44.54 $590,730 - $935,340	21,000 Added 166.67%	33,600 $1.19 Million
Q1 2022 May 16, 2022	BUY	$30.32 - $91.33 $382,032 - $1.15 Million	12,600 New	12,600 $513,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.